Synopsis of recent research by authors named "Qinlu Zhang"
- Qinlu Zhang's research primarily focuses on the intersection of cancer treatment and biomarker detection, exploring how gut microbiota can influence the efficacy of immune checkpoint inhibitors (ICIs) and developing novel biosensors for early diagnosis of various conditions.
- Recent studies include a detailed review on the role of gut microbiota in modulating the immune system's response to ICIs, highlighting the need for further understanding the underlying mechanisms to enhance treatment effectiveness.
- Zhang has also contributed to the development of innovative diagnostic tools, such as a lateral-flow immunoassay (LFIA) for detecting S100B as a brain damage biomarker, and assays for genotyping mutations linked to non-small cell lung cancer, showcasing the potential of nanoparticle technologies in clinical applications.